NEC Corporation and Biomy, Inc. have announced a groundbreaking partnership aimed at revolutionizing digital pathology through the integration of artificial intelligence (AI) and deep learning (DL). This collaboration, formalized in a recent Memorandum of Understanding (MoU), seeks to enhance
Artificial intelligence (AI) has garnered significant attention in recent years, particularly within the medical field for its potential to revolutionize various aspects of healthcare. The integration of AI in breast cancer detection promises not only an increase in accuracy but also a potential
Stanford Medicine researchers have recently introduced an innovative artificial intelligence (AI) model named MUSK (multimodal transformer with unified mask modeling) that significantly improves the accuracy of cancer prognosis predictions. By integrating both visual and textual medical data, this
The potential application of GPT-4, a large language model (LLM), in simplifying diabetes management by accurately interpreting continuous glucose monitoring (CGM) data and generating actionable insights is a promising development in healthcare. Researchers have been exploring innovative ways to
The field of drug discovery has long been challenged by the concept of "undruggable" targets—proteins and pathways that are crucial in disease processes but difficult to target with traditional small molecule drugs. One particularly challenging target is β-catenin, a key player in the Wnt/β-catenin
The healthcare industry is witnessing an unprecedented advancement with the introduction of AI-powered wearable cameras designed to detect and prevent medication errors. These errors are a significant concern, contributing to a substantial number of preventable harms, with medication errors alone
